|
1
|
Safety and immunogenicity of a Vero-cell-derived, inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial.
|
Lancet
|
2007
|
2.50
|
|
2
|
Platelet function in patients with acute coronary syndrome (ACS) predicts recurrent ACS.
|
J Thromb Haemost
|
2006
|
2.22
|
|
3
|
Massive pulmonary embolism leading to cardiac arrest is associated with consumptive coagulopathy presenting as disseminated intravascular coagulation.
|
J Thromb Haemost
|
2010
|
1.60
|
|
4
|
Acetaminophen has greater antipyretic efficacy than aspirin in endotoxemia: a randomized, double-blind, placebo-controlled trial.
|
Clin Pharmacol Ther
|
1999
|
1.50
|
|
5
|
Phenotyping vs. genotyping for prediction of clopidogrel efficacy and safety: the PEGASUS-PCI study.
|
J Thromb Haemost
|
2012
|
1.48
|
|
6
|
Paroxetine decreases platelet serotonin storage and platelet function in human beings.
|
Clin Pharmacol Ther
|
2000
|
1.46
|
|
7
|
Effects of erythropoietin on platelet reactivity and thrombopoiesis in humans.
|
Blood
|
2000
|
1.45
|
|
8
|
Polymorphism in the tissue factor region is associated with basal but not endotoxin-induced tissue factor-mRNA levels in leukocytes.
|
J Thromb Haemost
|
2006
|
1.43
|
|
9
|
Studies on the effect of short-term oral dihydroergotamine and troxerutin in patients with varicose veins.
|
Clin Pharmacol Ther
|
1994
|
1.40
|
|
10
|
Evidence of a U-shaped association between factor XII activity and overall survival.
|
J Thromb Haemost
|
2007
|
1.10
|
|
11
|
Heparin blunts endotoxin-induced coagulation activation.
|
Circulation
|
2000
|
1.09
|
|
12
|
Validation of rotation thrombelastography in a model of systemic activation of fibrinolysis and coagulation in humans.
|
J Thromb Haemost
|
2006
|
1.09
|
|
13
|
Fy phenotype and gender determine plasma levels of monocyte chemotactic protein.
|
Transfusion
|
2001
|
1.05
|
|
14
|
Effects of low dose endotoxemia on endothelial progenitor cells in humans.
|
Atherosclerosis
|
2007
|
1.02
|
|
15
|
Effect of proton pump inhibitors on clinical outcome in patients treated with clopidogrel: a systematic review and meta-analysis.
|
J Thromb Haemost
|
2010
|
1.01
|
|
16
|
Sex differences in HAART-associated dyslipidaemia.
|
AIDS
|
2001
|
1.00
|
|
17
|
Improved characteristics of aPC-resistance assay: Coatest aPC resistance by predilution of samples with factor V deficient plasma.
|
Am J Clin Pathol
|
1996
|
1.00
|
|
18
|
Multiple electrode aggregometry predicts stent thrombosis better than the vasodilator-stimulated phosphoprotein phosphorylation assay.
|
J Thromb Haemost
|
2009
|
0.97
|
|
19
|
Long-term immunogenicity of the new Vero cell-derived, inactivated Japanese encephalitis virus vaccine IC51 Six and 12 month results of a multicenter follow-up phase 3 study.
|
Vaccine
|
2008
|
0.95
|
|
20
|
Randomized, double-blind, placebo-controlled phase 3 trial of the safety and tolerability of IC51, an inactivated Japanese encephalitis vaccine.
|
J Infect Dis
|
2008
|
0.94
|
|
21
|
Racial differences in endotoxin-induced tissue factor-triggered coagulation.
|
J Thromb Haemost
|
2009
|
0.93
|
|
22
|
Sex differences in the association between albumin and all-cause and vascular mortality.
|
Eur J Clin Invest
|
2009
|
0.93
|
|
23
|
Persistent elevation and metabolic dependence of circulating E-selectin after delivery in women with gestational diabetes mellitus.
|
J Clin Endocrinol Metab
|
1997
|
0.92
|
|
24
|
Effects of endotoxemia on thrombopoiesis in men.
|
Thromb Haemost
|
1999
|
0.91
|
|
25
|
Monitoring of aspirin (ASA) pharmacodynamics with the platelet function analyzer PFA-100.
|
Thromb Haemost
|
2000
|
0.91
|
|
26
|
Role of von Willebrand factor in vascular disease.
|
Hamostaseologie
|
2009
|
0.89
|
|
27
|
Inhibition of tissue factor pathway inhibitor by the aptamer BAX499 improves clotting of hemophilic blood and plasma.
|
J Thromb Haemost
|
2012
|
0.89
|
|
28
|
Lepirudin blunts endotoxin-induced coagulation activation.
|
Blood
|
2000
|
0.89
|
|
29
|
Morning hypercoagulability and hypofibrinolysis. Diurnal variations in circulating activated factor VII, prothrombin fragment F1+2, and plasmin-plasmin inhibitor complex.
|
Circulation
|
1997
|
0.88
|
|
30
|
Effect of intradermal tumor necrosis factor-alpha-induced inflammation on coagulation factors in dermal vessel endothelium. An in vivo study of human skin biopsies.
|
Thromb Haemost
|
2001
|
0.87
|
|
31
|
Low-dose aspirin does not lower in vivo platelet activation in healthy smokers.
|
Br J Haematol
|
1998
|
0.86
|
|
32
|
Fosinopril decreases levels of soluble vascular cell adhesion molecule-1 in borderline hypertensive type II diabetic patients with microalbuminuria.
|
Am J Hypertens
|
1999
|
0.86
|
|
33
|
Endotoxin-induced activation of the coagulation cascade in humans: effect of acetylsalicylic acid and acetaminophen.
|
Arterioscler Thromb Vasc Biol
|
1999
|
0.85
|
|
34
|
Impaired platelet function among platelet donors.
|
Thromb Haemost
|
2001
|
0.83
|
|
35
|
Comparison of the effects of ketamine and memantine on prolactin and cortisol release in men. a randomized, double-blind, placebo-controlled trial.
|
Neuropsychopharmacology
|
2001
|
0.83
|
|
36
|
Plasma levels of activated factor VII decrease during the menstrual cycle.
|
Thromb Haemost
|
1998
|
0.83
|
|
37
|
Partial inhibition of nitric oxide synthase primes the stimulated pathway of vWF-secretion in man.
|
Atherosclerosis
|
2000
|
0.83
|
|
38
|
High levels of reticulated platelets and thrombopoietin characterize fetal thrombopoiesis.
|
Br J Haematol
|
2001
|
0.83
|
|
39
|
Reparixin, a specific interleukin-8 inhibitor, has no effects on inflammation during endotoxemia.
|
Int J Immunopathol Pharmacol
|
2007
|
0.82
|
|
40
|
Direct evidence for an increase in thrombopoiesis after liver transplantation.
|
Eur J Clin Invest
|
1998
|
0.82
|
|
41
|
The effect of plasma removal from apheresis platelet concentrates on platelet function.
|
Vox Sang
|
2011
|
0.81
|
|
42
|
Influence of the Duffy antigen on pharmacokinetics and pharmacodynamics of recombinant monocyte chemoattractant protein (MCP-1, CCL-2) in vivo.
|
Int J Immunopathol Pharmacol
|
2009
|
0.80
|
|
43
|
Endotoxin down-modulates granulocyte colony-stimulating factor receptor (CD114) on human neutrophils.
|
J Infect Dis
|
2000
|
0.80
|
|
44
|
Endotoxemia enhances circulating endothelial cells in humans.
|
J Thromb Haemost
|
2006
|
0.79
|
|
45
|
Strain differences in toxic effects of long-lasting isoflurane anaesthesia between Wistar rats and Sprague Dawley rats.
|
Food Chem Toxicol
|
2008
|
0.79
|
|
46
|
Systemic inflammation increases shear stress-induced platelet plug formation measured by the PFA-100.
|
Br J Haematol
|
2000
|
0.79
|
|
47
|
Influence of angiotensin II on circulating adhesion molecules and blood leukocyte count in vivo.
|
Can J Physiol Pharmacol
|
1996
|
0.79
|
|
48
|
Effects of endothelin-1 (ET-1) on ocular hemodynamics.
|
Curr Eye Res
|
1997
|
0.79
|
|
49
|
Hypertensive emergencies are associated with elevated markers of inflammation, coagulation, platelet activation and fibrinolysis.
|
J Hum Hypertens
|
2012
|
0.78
|
|
50
|
Time lag in platelet function inhibition by clopidogrel in stroke patients as measured by PFA-100.
|
J Thromb Haemost
|
2004
|
0.78
|
|
51
|
Marked increase in vascular endothelial growth factor concentrations during Escherichia coli endotoxin-induced acute inflammation in humans.
|
Eur J Clin Invest
|
2003
|
0.78
|
|
52
|
Troponin T predicts in-hospital and 1-year mortality in patients with pulmonary embolism.
|
Eur Respir J
|
2009
|
0.78
|
|
53
|
A pilot study on reparixin, a CXCR1/2 antagonist, to assess safety and efficacy in attenuating ischaemia-reperfusion injury and inflammation after on-pump coronary artery bypass graft surgery.
|
Clin Exp Immunol
|
2015
|
0.78
|
|
54
|
Enhanced blood coagulation and enhanced fibrinolysis during hemodialysis with prostacyclin.
|
Thromb Res
|
1997
|
0.78
|
|
55
|
Evaluation of bedside prothrombin time and activated partial thromboplastin time measurement by coagulation analyzer CoaguCheck Plus in various clinical settings.
|
Thromb Res
|
1997
|
0.78
|
|
56
|
Differential induction of P-selectin expression on platelets by two cell separators during plateletpheresis and the effect of gender on the release of soluble P-selectin.
|
Transfusion
|
1998
|
0.78
|
|
57
|
Sex differences in circulating P-selectin, E-selectin and thrombomodulin.
|
Br J Haematol
|
1996
|
0.78
|
|
58
|
Man, mouse and Duffy genotype-phenotype-specific pharmacokinetics of monocyte chemotactic protein-1.
|
Transfus Med
|
2004
|
0.78
|
|
59
|
Effects of anticoagulation on thrombopoietin release during endotoxemia.
|
J Lab Clin Med
|
2001
|
0.77
|
|
60
|
Regional cortical development in very low birth weight infants with normal neurodevelopmental outcome assessed by 3D-ultrasound.
|
J Perinatol
|
2012
|
0.77
|
|
61
|
Short- and long-term effects of therapy with interferon-alpha and pegylated interferon-alpha/ribavirin on platelet plug formation and von Willebrand factor release in patients with chronic hepatitis C.
|
Aliment Pharmacol Ther
|
2005
|
0.77
|
|
62
|
Beneficial effects of protease inhibitors on body composition and energy expenditure: a comparison between HIV-infected and AIDS patients.
|
AIDS
|
1999
|
0.77
|
|
63
|
Inhibitory activity of aspirin on von Willebrand factor-induced platelet aggregation.
|
Thromb Res
|
2000
|
0.77
|
|
64
|
Effects of heparin and aspirin on circulating P-selectin, E-selectin and von Willebrand Factor levels in healthy men.
|
Atherosclerosis
|
2001
|
0.77
|
|
65
|
Physiochemical properties, safety and pharmacokinetics of bimosiamose disodium after intravenous administration.
|
Int J Clin Pharmacol Ther
|
2005
|
0.77
|
|
66
|
Potential biomarkers of an exaggerated response to endotoxemia.
|
Biomarkers
|
2007
|
0.76
|
|
67
|
Detecting aspirin resistance with the platelet function analyzer (PFA-100).
|
Am J Cardiol
|
2001
|
0.76
|
|
68
|
Elevated numbers of reticulated platelets in hyperthyroidism: direct evidence for an increase of thrombopoiesis.
|
Br J Haematol
|
1998
|
0.76
|
|
69
|
Measurement of the levels of reticulated platelets after plateletpheresis to monitor activity of thrombopoiesis.
|
Transfusion
|
1998
|
0.76
|
|
70
|
Evidence against an effect of endothelin-1 on blood coagulation, fibrinolysis, and endothelial cell integrity in healthy men.
|
Arterioscler Thromb Vasc Biol
|
1997
|
0.75
|
|
71
|
Soluble P-selectin in diabetes.
|
Thromb Haemost
|
1999
|
0.75
|
|
72
|
Dexamethasone downregulates L-selectin in vitro and in vivo.
|
Circulation
|
1998
|
0.75
|
|
73
|
Granulocyte colony-stimulating factor and cytokine release.
|
Clin Pharmacol Ther
|
2000
|
0.75
|
|
74
|
Surrogate markers to monitor efficacy of anticoagulants or antiplatelet drugs in atrial fibrillation.
|
Eur Heart J
|
2002
|
0.75
|
|
75
|
Pharmacokinetics and pharmacodynamics of the dual FII/FX inhibitor BIBT 986 in endotoxin-induced coagulation.
|
Clin Pharmacol Ther
|
2007
|
0.75
|
|
76
|
Safety issues of plateletpheresis: comparison of the effects of two cell separators on the activation of coagulation, fibrinolysis, and neutrophils and on the formation of neutrophil-platelet aggregates.
|
Transfusion
|
1999
|
0.75
|
|
77
|
The platelet alpha2-integrin (GPIa) nucleotide-807 polymorphism is not associated with a risk for maternal-fetal human platelet antigen-5 incompatibility.
|
Ann Hematol
|
2000
|
0.75
|
|
78
|
Rofecoxib exerts no effect on platelet plug formation in healthy volunteers.
|
Clin Exp Rheumatol
|
2003
|
0.75
|
|
79
|
The association of the Thr715Pro P-selectin genotype with levels of P-selectin in platelet concentrates.
|
Vox Sang
|
2014
|
0.75
|
|
80
|
Thrombopoiesis is increased in hyperthyroidism.
|
J Clin Endocrinol Metab
|
1998
|
0.75
|
|
81
|
Fosinopril decreases levels of soluble vascular cell adhesion molecule-1 in Type II diabetic patients suffering from microalbuminuria.
|
Diabetologia
|
1998
|
0.75
|
|
82
|
Immunoglobulin administration to fetuses with anemia due to alloimmunization to D.
|
Transfusion
|
2000
|
0.75
|
|
83
|
Putative role of adhesion molecules in metabolic disorders.
|
Horm Metab Res
|
1997
|
0.75
|
|
84
|
Delayed effect of desmopressin on circulating neutrophils and monocytes.
|
Br J Haematol
|
1996
|
0.75
|
|
85
|
Evaluation of a new screening assay ProC Global for identification of defects in the protein C/protein S anticoagulant pathway.
|
Thromb Res
|
1997
|
0.75
|
|
86
|
Heparin lowers plasma levels of activated factor VII.
|
Br J Haematol
|
1999
|
0.75
|
|
87
|
Does phosphodiesterase III inhibition reverse the cardiodepressive effects of propofol?
|
Anesth Analg
|
1997
|
0.75
|
|
88
|
Effects of nitroglycerin and sodium nitroprusside on endexpiratory concentrations of nitric oxide in healthy humans.
|
Life Sci
|
1998
|
0.75
|
|
89
|
Effects of indomethacin on the L-selectin expression in humans.
|
Scand J Immunol
|
2001
|
0.75
|
|
90
|
The pharmacokinetics and pharmacodynamics of a new sustained-release leuprolide acetate depot compared to market references.
|
Int J Clin Pharmacol Ther
|
2008
|
0.75
|
|
91
|
The proportion of reticulated platelets is higher in bone marrow than in peripheral blood in haematological patients.
|
Eur J Haematol
|
1999
|
0.75
|
|
92
|
A new flow cytometric method for simultaneous measurement of residual platelets and RBCs in plasma: validation and application for QC.
|
Transfusion
|
2001
|
0.75
|
|
93
|
Pharmacokinetics and pharmacodynamics of BIBT 986, a novel small molecule dual inhibitor of thrombin and factor Xa.
|
J Thromb Haemost
|
2006
|
0.75
|
|
94
|
Effects of neuropeptide Y and vasoactive intestinal peptide on human venous smooth muscle in vivo.
|
Naunyn Schmiedebergs Arch Pharmacol
|
1994
|
0.75
|
|
95
|
Effects of nitric oxide on platelet activation during plateletpheresis and in vivo tracking of biotinylated platelets in humans.
|
Transfusion
|
1999
|
0.75
|